The median alpha-fetoprotein (AFP) level was significantly higher in the nonsurvivor group than in the survivor group (P < 0.001), and the median follow-up period was longer in the HCC survivor group than in the nonsurvivor group (P < 0.001). This evidence concerns the gene AFP and hepatocellular carcinoma.